• 3352 Citations
  • 33 h-Index
1992 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Maria Lina Tornesello is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
HIV-1 Medicine & Life Sciences
Virion Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Vaccines Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
HIV Medicine & Life Sciences
Viruses Chemical Compounds
Human papillomavirus 16 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

  • 3352 Citations
  • 33 h-Index
  • 153 Article
  • 7 Review article
  • 4 Chapter
  • 1 Editorial

Cancer diagnostic and predictive biomarkers 2018

Buonaguro, F. M., Caposio, P., Tornesello, M. L., De Re, V. & Franco, R., Jan 1 2019, In : BioMed Research International. 2019, 3879015.

Research output: Contribution to journalEditorial

Clinical significance of polymorphisms in immune response genes in hepatitis C-related hepatocellular carcinoma

De Re, V., Tornesello, M. L., De Zorzi, M., Caggiari, L., Pezzuto, F., Leone, P., Racanelli, V., Lauletta, G., Gragnani, L., Buonadonna, A., Vaccher, E., Zignego, A. L., Steffan, A. & Buonaguro, F. M., Jan 1 2019, In : Frontiers in Microbiology. 10, MAR, 475.

Research output: Contribution to journalArticle

Open Access
Hepatitis C
Hepacivirus
Hepatocellular Carcinoma
Genes
Virus Diseases

High somatic mutation and neoantigen burden do not correlate with decreased progression-free survival in hcc patients not undergoing immunotherapy

Mauriello, A., Zeuli, R., Cavalluzzo, B., Petrizzo, A., Tornesello, M. L., Buonaguro, F. M., Ceccarelli, M., Tagliamonte, M. & Buonaguro, L., Dec 2019, In : Cancers. 11, 12, 1824.

Research output: Contribution to journalArticle

Open Access
Immunotherapy
Disease-Free Survival
Mutation
Survival
Granzymes

Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma

Löffler, M. W., Mohr, C., Bichmann, L., Freudenmann, L. K., Walzer, M., Schroeder, C. M., Trautwein, N., Hilke, F. J., Zinser, R. S., Mühlenbruch, L., Kowalewski, D. J., Schuster, H., Sturm, M., Matthes, J., Riess, O., Czemmel, S., Nahnsen, S., Königsrainer, I., Thiel, K., Nadalin, S. & 30 others, Beckert, S., Bösmüller, H., Fend, F., Velic, A., Maček, B., Haen, S. P., Buonaguro, L., Kohlbacher, O., Stevanović, S., Königsrainer, A., Rammensee, H. G., Mayer-Mokler, A., Weinschenk, T., Flohr, C., Reinhardt, C., Singh-Jasuja, H., Accolla, R. S., Tosi, G., Forlani, G., Ma, Y. T., Adams, D., Valmori, D., Chaumette, T., Heidenreich, R., Gouttefangeas, C., Sangro, B., Tagliamonte, M., Petrizzo, A., Tornesello, M. L. & Buonaguro, F. M., Apr 30 2019, In : Genome Medicine. 11, 1, 28.

Research output: Contribution to journalArticle

Open Access
Exome
Hepatocellular Carcinoma
Ligands
Melanoma
Mutation

Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms

Tafuto, S., von Arx, C., Capozzi, M., Tatangelo, F., Mura, M., Modica, R., Barretta, M. L., Di Sarno, A., Tornesello, M. L., Colao, A. & Ottaiano, A., Aug 15 2019, In : Journal of Clinical Medicine. 8, 8

Research output: Contribution to journalArticle

temozolomide
Safety
Neoplasms
Therapeutics
Dacarbazine